Kolexia
Chapuy-Regaud Sabine Pharmacien
Chapuy-Regaud Sabine
Pharmacien
Hôpital Purpan
Toulouse, France
53 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite E Hépatite COVID-19 Arthrite Polyarthrite rhumatoïde Infection par le virus Zika Pneumopathie infectieuse Infection persistante Zoonoses

Collaborateurs

Voir plus
Izopet Jacques
Izopet Jacques
Hôpital Purpan, Toulouse, France
Abravanel Florence
Abravanel Florence
Hôpital Purpan, Toulouse, France
Lhomme Sebastien
Lhomme Sebastien
Hôpital Purpan, Toulouse, France
Mansuy Jean-Michel
Mansuy Jean-Michel
Hôpital Purpan, Toulouse, France

Industries

Voir plus
MSD
2 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
COVIDBioToul: Identification of Predictive Immune Biomarkers Based on the Understanding of COVID-19 Pathogenesis to Influence Therapeutic Management
Essai Clinique (CHU Toulouse)   26 juillet 2023
Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infection.
Journal of medical virology   17 octobre 2022
Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection.
Vaccines   17 septembre 2022
Post-vaccination SARS-CoV-2 antibody kinetics and protection duration against Omicron in elderly population.
The Journal of infection   03 septembre 2022
Post-Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Kinetics and Protection Duration.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   29 août 2022
Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant.
Microbiology spectrum   05 juillet 2022
Diagnostic Performance of an Automated System for Assaying Anti-Hepatitis E Virus Immunoglobulins M and G Compared with a Conventional Microplate Assay.
Viruses   17 mai 2022
Comparative effects of mRNA vaccine booster and natural Omicron infection on the neutralizing antibody response.
The Journal of infection   07 mai 2022
Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   12 avril 2022
Casirivimab-imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients.
Transplantation   08 mars 2022